Search by Drug Name or NDC

    NDC 24689-0123-01 Guaifenesin and Dextromethorphan Hydrobromide 20; 400 mg/1; mg/1 Details

    Guaifenesin and Dextromethorphan Hydrobromide 20; 400 mg/1; mg/1

    Guaifenesin and Dextromethorphan Hydrobromide is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by APNAR PHARMA LP. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 24689-0123
    Product ID 24689-123_f17dcc88-303d-4e1f-e053-2a95a90ae08d
    Associated GPIs
    GCN Sequence Number 058386
    GCN Sequence Number Description guaifenesin/dextromethorphan TABLET 400MG-20MG ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 23807
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Guaifenesin and Dextromethorphan Hydrobromide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin and Dextromethorphan Hydrobromide
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 20; 400
    Active Ingredient Units mg/1; mg/1
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name APNAR PHARMA LP
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 24689-0123-01 (24689012301)

    NDC Package Code 24689-123-01
    Billing NDC 24689012301
    Package 20 TABLET in 1 BOTTLE (24689-123-01)
    Marketing Start Date 2022-12-30
    NDC Exclude Flag N
    Pricing Information N/A